Search

3869 Results

How MSF Brought Down the Price of the Pneumonia Vaccine

In 2016, MSF's Access Campaign succeeded in getting pharmaceutical giants Pfizer and GlaxoSmithKline to significantly drop the price of the pneumonia vaccine for humanitarian organisations working in emergency settings.
Videos and Photos - 19 Oct 2017

Yemen

The last remnants of the Yemen health system

In the emergency room of the Al Kuwait hospital, Yemen, dozens of staff continue to work, even though they haven’t received their salaries for a year.
Patient and Staff Stories - 18 Oct 2017

HIV/Aids

Malawi: Daily struggles of the most vulnerable

Malawi has one of the most successful, innovative HIV programmes in the region after being heavily affected by the HIV epidemic in the late 90s.
Videos and Photos - 18 Oct 2017

Iraq

Mosul: Returnees face booby-trapped homes

Press Release - 17 Oct 2017

Tuberculosis

Drug-Resistant Tuberculosis Treatment & Access to Delamanid in South Africa

Delamanid is one of the first new medicines developed for DR-TB treatment in 50 years. The standard treatment duration is for the first six months of DR-TB treatment. The WHO issued interim guidelines on DLM use to treat MDR-TB in November 2014 and on its use in treating children and adolescents in 2016. Delamanid is also included in the 19th WHO Model List of Essential medicines.
Briefing Document - 13 Oct 2017